Viewing Study NCT06041503


Ignite Creation Date: 2025-12-24 @ 7:09 PM
Ignite Modification Date: 2025-12-27 @ 2:03 PM
Study NCT ID: NCT06041503
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-12-24
First Post: 2023-09-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Enfortumab Vedotin With or Without Pembrolizumab in Rare Genitourinary Tumors (E-VIRTUE)
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module